Evidence map›Paper›PMID 37238179›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Application of Deep Learning Methods in a Moroccan Ophthalmic Center: Analysis and Discussion.

Zineb Farahat, Nabila Zrira, Nissrine Souissi, Safia Benamar, Mohammed Belmekki, Mohamed Nabil Ngote, Kawtar Megdiche

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zineb FarahatLISTD Laboratory, Ecole Nationale Supérieure des Mines de Rabat, Rabat 10000, Morocco.
Nabila ZriraLISTD Laboratory, Ecole Nationale Supérieure des Mines de Rabat, Rabat 10000, Morocco.
Nissrine SouissiLISTD Laboratory, Ecole Nationale Supérieure des Mines de Rabat, Rabat 10000, Morocco.ORCID 0000-0002-5593-4674
Safia BenamarCheikh Zaïd Ophthalmic Center, Cheikh Zaïd International University Hospital, Rabat 10000, Morocco.
Mohammed BelmekkiCheikh Zaïd Ophthalmic Center, Cheikh Zaïd International University Hospital, Rabat 10000, Morocco.
Mohamed Nabil NgoteLISTD Laboratory, Ecole Nationale Supérieure des Mines de Rabat, Rabat 10000, Morocco.
Kawtar MegdicheCheikh Zaïd Foundation Medical Simulation Center, Rabat 10000, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) remains one of the world's frequent eye illnesses, leading to vision loss among working-aged individuals. Hemorrhages and exudates are examples of signs of DR. However, artificial intelligence (AI), particularly deep learning (DL), is poised to impact nearly every aspect of human life and gradually transform medical practice. Insight into the condition of the retina is becoming more accessible thanks to major advancements in diagnostic technology. AI approaches can be used to assess lots of morphological datasets derived from digital images in a rapid and noninvasive manner. Computer-aided diagnosis tools for automatic detection of DR early-stage signs will ease the pressure on clinicians. In this work, we apply two methods to the color fundus images taken on-site at the Cheikh Zaïd Foundation's Ophthalmic Center in Rabat to detect both exudates and hemorrhages. First, we apply the U-Net method to segment exudates and hemorrhages into red and green colors, respectively. Second, the You Look Only Once Version 5 (YOLOv5) method identifies the presence of hemorrhages and exudates in an image and predicts a probability for each bounding box. The segmentation proposed method obtained a specificity of 85%, a sensitivity of 85%, and a Dice score of 85%. The detection software successfully detected 100% of diabetic retinopathy signs, the expert doctor detected 99% of DR signs, and the resident doctor detected 84%.

Indexed as

artificial intelligenceautomatic screeningdeep learningdiabetic retinopathyexudateshemorrhagesmethodU-NetYOLOv5

Identifiers

PMID37238179
PMCPMC10216938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.